Gene · 28882
Papers3,857
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 3,857
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pulsed Electromagnetic Fields (PEMF)-Physiological Response and Its Potential in Trauma Treatment. | Int J Mol Sci | 2023 | 37510998 | PubTator, text mining | PubMed |
| Therapeutic Targets of Monoclonal Antibodies Used in the Treatment of Cancer: Current and Emerging. | Biomedicines | 2023 | 37509725 | PubTator, text mining | PubMed |
| Unlocking the Therapeutic Potential of Ulotaront as a Trace Amine-Associated Receptor 1 Agonist for Neuropsychiatric Disorders. | Biomedicines | 2023 | 37509616 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing reveals tumor immune microenvironment in human hypopharygeal squamous cell carcinoma and lymphatic metastasis. | Front Immunol | 2023 | 37503341 | PubTator, text mining | PubMed |
| Radiomics using computed tomography to predict CD73 expression and prognosis of colorectal cancer liver metastases. | J Transl Med | 2023 | 37501197 | PubTator, text mining | PubMed |
| Periprostatic adipose tissue (PPAT) supernatant from obese mice releases anticontractile substances and increases human prostate epithelial cell proliferation: the role of nitric oxide and adenosine. | Front Pharmacol | 2023 | 37492091 | PubTator, text mining | PubMed |
| Saikosaponin D reverses epinephrine- and norepinephrine-induced gemcitabine resistance in intrahepatic cholangiocarcinoma by downregulating ADRB2/glycolysis signaling. | Acta Biochim Biophys Sin (Shanghai) | 2023 | 37489008 | PubTator, text mining | PubMed |
| Anti-nanodisc antibodies specifically capture nanodiscs and facilitate molecular interaction kinetics studies for membrane protein. | Sci Rep | 2023 | 37468499 | PubTator, text mining | PubMed |
| Damage-mediated macrophage polarization in sterile inflammation. | Front Immunol | 2023 | 37465676 | PubTator, text mining | PubMed |
| Aberration correction in 2D echocardiography. | Quant Imaging Med Surg | 2023 | 37456280 | PubTator, text mining | PubMed |
| Adenosine signaling as target in cardiovascular pharmacology. | Curr Opin Pharmacol | 2023 | 37450948 | PubTator, text mining | PubMed |
| [Primary bilateral macronodular adrenal hyperplasia: clinical and laboratory features]. | Probl Endokrinol (Mosk) | 2023 | 37448248 | PubTator, text mining | PubMed |
| Pathophysiological and Molecular Basis of the Side Effects of Ticagrelor: Lessons from a Case Report. | Int J Mol Sci | 2023 | 37446022 | PubTator, text mining | PubMed |
| Imiquimod as Local Immunotherapy in the Management of Premalignant Cutaneous Conditions and Skin Cancer. | Int J Mol Sci | 2023 | 37446011 | PubTator, text mining | PubMed |
| Levodopa-Induced Dyskinesias in Parkinson's Disease: An Overview on Pathophysiology, Clinical Manifestations, Therapy Management Strategies and Future Directions. | J Clin Med | 2023 | 37445461 | PubTator, text mining | PubMed |
| The effects of caffeine and d-amphetamine on spatial span task in healthy participants. | PLoS One | 2023 | 37440493 | PubTator, text mining | PubMed |
| Innate Immune System in the Pathogenesis of Non-Alcoholic Fatty Liver Disease. | Nutrients | 2023 | 37432213 | PubTator, text mining | PubMed |
| Optical Approaches for Investigating Neuromodulation and G Protein-Coupled Receptor Signaling. | Pharmacol Rev | 2023 | 37429736 | PubTator, text mining | PubMed |
| Role of the Sympathetic Nervous System in Mild Chronic Inflammatory Diseases: Focus on Osteoarthritis. | Neuroimmunomodulation | 2023 | 37429263 | PubTator, text mining | PubMed |
| Underlying pharmacological mechanisms of psilocin-induced broadband desynchronization and disconnection of EEG in rats. | Front Neurosci | 2023 | 37425017 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/28882/papers?page=12